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ABSTRACT
The lateral division of the central nucleus of the amygdala (CEAl) and the oval nucleus of
the bed nucleus of the stria terminalis (BSTov) have been linked closely anatomically and
functionally. To determine whether these regions may be subdivided further on a neurochemi-
cal basis, dual in situ hybridization was used to determine the colocalization of corticotropin-
releasing hormone (CRH), enkephalin (ENK), or neurotensin (NT) with glutamic acid
decarboxylase isoforms 65 and 67 [used concurrently as a marker for g-aminobutyric acid
GABA] in these nuclei. It was found that, for both regions, each peptide invariably was
localized in a GABAergic cell. Although there was a similar overlap in the distribution of NT
with ENK in the BSTov and CEAl, it was observed that CRH and ENK rarely were colocalized
in either nucleus. To determine whether these distinct neuronal populations could be
activated differentially, male rats were given a systemic injection of interleukin-1b (IL-1b; 5
µg/kg, i.p.), a stimulus that results in a robust increase in c-fos mRNA expression in the BSTov
and CEAl. The neurochemical identity of these activated neurons showed striking similarities
between the BSTov and the CEAl; All IL-1b-responsive cells were GABAergic, the majority of
c-fos- positive cells expressed ENK mRNA (BSTov, 81%; CEAl, 94%), and some expressed NT
mRNA (BSTov, 23%; CEAl, 22%), whereas very few expressed CRH mRNA (BSTov, 4%; CEAl,
1%). These data provide evidence for the existence of discrete neural circuits within the BSTov
and CEAl, and the similarities in the patterns of neurochemical colocalization in these nuclei
are consistent with the concept of an extended amygdala. Furthermore, these data indicate
that intraperitoneal IL-1b recruits neurochemically distinct pathways within the BSTov and
CEAl, and it is suggested that this differential activation may mediate specific aspects of
immune, limbic, and/or autonomic processes. J. Comp. Neurol. 413:113–128, 1999.
r 1999 Wiley-Liss, Inc.
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A significant body of work has demonstrated both ana-
tomical and functional similarities between the lateral
division of the central nucleus of the amygdala (CEAl) and
the oval nucleus of the bed nucleus of the stria terminalis
(BSTov: Ju and Swanson, 1989; Ju et al., 1989; Swanson
1992; equivalent to the dorsal lateral subnucleus of Moga
et al., 1989). Indeed, together with the substantia inomi-
nata, it has been proposed that these structures form the
central extended amygdala (for review, Alheid et al., 1995).
Although it is not the purpose of this article to review all of
the anatomical connections of these nuclei, it is worth
noting the strong topographic projections from the CEA to
the BST (Sun et al., 1991). Furthermore, both structures
are connected reciprocally with the parabrachial nucleus
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(Moga and Gray, 1985; Moga et al., 1989; Bernard et al.,
1993; Krukoff et al., 1993; Alden et al., 1994) and the
nucleus tractus solitarius (NTS; Ricardo and Koh, 1978;
Gray and Magnuson, 1987), and they share a number of
other common efferent and afferent inputs, as outlined in
more detail below. Although the functional significance of
activation of these regions is not clear, together, they are
thought to be involved in the coordination of central
autonomic function (Saper, 1995). Furthermore, the BST
and CEA have been associated with the elicitation and
integration of behavioral and possibly emotional responses
to anxiety, fear, and stress (Davis, 1992; Gallagher and
Chiba, 1996; Maren and Fanselow, 1996).
With such a diverse array of complex functions ascribed
to the BST and CEA, it is not surprising that these nuclei
receive inputs from a wide variety of sources. For example,
cortical areas (Hurley et al., 1991; Sun et al., 1994;
McDonald and Mascagni, 1997), thalamic areas (Moga et
al., 1995), hypothalamic areas (Cullinan and Zaborsky,
1991; Canteras et al., 1994; Vertes et al., 1995), and
brainstem areas (Ricardo and Koh, 1978; Bernard et al.,
1993; Krukoff et al., 1993; Alden et al., 1994) as well as
other amygdaloid nuclei (Weller and Smith, 1982; Can-
teras et al., 1995; Savander et al., 1995, 1996) have been
shown to project to the BST and the CEA. To achieve
functional differentiation, there is a considerable degree of
anatomical specificity within the BST and CEA in the
targets of these different inputs. For example, a subset of
cortical areas (Sun et al., 1994; McDonald and Mascagni,
1997), thalamic areas (Moga et al., 1995), and brainstem
areas (Ricardo and Koh, 1978; Krukoff et al., 1993) project
to the CEAl. Within the CEAl, although it appears that
inputs from these different origins overlap broadly, one
way in which further functional separation may be gained
is by targeting distinct neurochemical subpopulations
within the nucleus. Although these neurons may be differ-
ent functionally, because they are in close proximity to one
another, their roles may become integrated and coordi-
nated. In addition, if these patterns of segregation appear
consistently across other components of the central ex-
tended amygdala, then this would lend support to the
proposed coherent nature and functional relevance of
these areas.
Several studies have been published describing the
distribution of various peptides in the BST and the CEA
(Wray and Hoffman, 1983; Cassell et al., 1986; Ju et al.,
1989; Moga et al., 1989; Shimada et al., 1989). Although
these studies have demonstrated similarities in the expres-
sion of a number of peptides between the BSTov and the
CEAl, they also have indicated that, within these subnu-
clei, there is differential peptide expression. The few
colocalization studies that have been published indicate
that there may be neurochemically distinct neuronal popu-
lations within the BSTov and the CEAl (Oertel et al., 1983;
Shimada et al., 1989; Veinante et al., 1997). Furthermore,
these two nuclei are known to be highly g-aminobutyric
acidergic (GABAergic; Sun and Cassell, 1993), and there is
some evidence from immunocytochemical studies on adja-
cent sections to suggest that GABAergic neurons of the
BSTov and the CEAl synthesize either corticotropin-
releasing hormone (CRH) or enkephalin (ENK; Veinante
et al., 1997).
In this study, a double in situ hybridization (ISH)
technique was used to extend these findings in experimen-
tally naı̈ve adult male rats. The degree of colocalization of
ENK, neurotensin (NT), or CRH mRNA in GABAergic
neurons of the BSTov and the CEAl was determined
initially. Furthermore, we determined whether or not CRH
or NT mRNA was expressed in enkephalinergic cells.
These studies revealed a highly discrete pattern of peptide
colocalization, and we went on to ask whether these
neurochemically distinct neuronal populations of the BSTov
and CEAl could be activated selectively by an intraperito-
neal injection of interleukin-1b (IL-1b). This stimulus is
known to elicit c-fos mRNA expression in the BSTov and
CEAl (Brady et al., 1994; Day and Akil, 1996), which is
thought to reflect synaptic or transcriptional activation.
The extent of colocalization of IL-1b-induced c-fos mRNA
in GABAergic neurons and in cells that express ENK, NT,
or CRH mRNA in the BSTov or CEAl was established.
Preliminary data from this work were presented previ-
ously in abstract form (Day et al., 1996).
MATERIALS AND METHODS
Animals
All animal procedures were approved by University of
Michigan Committee on Use and Care of Animals. Male
Sprague-Dawley rats (Charles River Laboratories, Wilm-
ington, MA), weighing 250–300 g were used. Rats were
housed five or six per cage under conditions of constant
temperature and humidity on a 12-hour light/dark cycle
(lights on at 0600) with access to food and water ad
libitum. Six rats that were naı̈ve to handling or other
treatment regimens were used for neurochemical colocal-
ization studies. Animals that received saline (n 5 5) or
IL-1b injections (n 5 6) were handled daily for 1 week prior
to the experiment.
Administration of IL-1b
IL-1b (human, recombinant) was obtained from Bachem
(Torrance, CA). The manufacturer’s specifications stated
that endotoxin levels were , 0.1 ng per µg of IL-1b. The
specific activity was approximately 5 3 107 U/mg protein.
Animals were given an intraperitoneal (i.p.) injection of
IL-1b, (5 µg/ml/kg; n 5 6) or an equivalent volume of 0.9%
sterile, pyrogen-free saline (n 5 5) and were returned to
their home cage. Injections were given 2–3 hours after the
onset of the light period.
Tissue preparation
Animals were rapidly decapitated directly after being
removed from the home cage for naı̈ve rats or 30 minutes
after injection of IL-1b or saline. Brains were removed and
frozen in isopentane cooled to between 240°C and 250°C
and were stored at 280°C. Sections (10 µm thick) were cut
on a cryostat (Bright, Huntingdon, United Kingdom)
through the BST (approximately 0.20 to 20.80 mm from
Bregma) and CEA (approximately 21.80 to 23.60 mm
from Bregma) and thaw mounted onto polylysine-coated
slides. Tissue was air dried and stored at 280°C until
processing for ISH.
Double ISH histochemistry
The method used for double ISH was adapted from that
described by Curran and Watson (1995). The specificity of
the probes was confirmed in control experiments by using
sense probes or tissue that had been pretreated with
RNase A (200 µg/ml) for 1 hour at 37°C prior to hybridiza-
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tion with antisense probes. No specific hybridization was
observed for any of the controls.
Probes
cRNA probes complementary to c-fos (680 mer; courtesy
of Dr. T. Curran, St. Jude Children’s Research Hospital,
Memphis, TN), glutamic acid decarboxylase 65 (GAD65;
230 mer; courtesy of Dr. N.J.K. Tillakaratne, University of
California), GAD67 (210 mer; courtesy of Dr. A. Tobin,
University of California-Los Angeles), ENK (693 mer;
courtesy of Dr. J. Douglass, Amgen, Inc., Thousand Oaks,
CA), NT (587 mer; courtesy of Dr. P. Dobner, University of
Massachusetts), and CRH (770 mer; courtesy of Dr. R.
Thompson, University of Michigan) were used.
To generate 35S-labeled cRNA probes, linearized plasmid
(1 µg) was incubated at 37°C for 2 hours in 1 3 transcrip-
tion buffer (Gibco BRL, Grand Island, NY), 75 µCi a-[35S]-
UTP ($ 1,000 Ci/mmol; 20 mCi/ml; Amersham, Arlington
Heights, IL), 100 µCi a-[35S]-CTP (800 Ci/mmol; 40 mCi/
ml; Amersham), 400 µM ATP, 400 µM GTP, 10 mM dithio-
threitol (DTT), 20 U RNase inhibitor, and 6 U appropriate
RNA polymerase. To generate a nonradioactive labeled
probe, digoxigenin-UTP (Dig-UTP; Boehringer Mann-
heim, Indianapolis, IN) was used. Linearized plasmid (1
µg) was incubated at 37°C for 2 hours in 1 3 transcription
buffer, 400 µM ATP, 400 µM CTP, 400 µM GTP, 80–260 µM
UTP, 140–320 µM Dig-UTP (total UTP 1 Dig-UTP 5 400
µM), 10 mM DTT, 20 U RNase inhibitor, and 6 U appropri-
ate RNA polymerase. The resulting probes were separated
from free nucleotides on a Sephadex G50–50 column. The
fractions containing Dig-UTP-labeled probe were deter-
mined by performing a small-scale color reaction (see
below) on 1 µl each fraction blotted onto Nytran mem-
brane.
Before hybridization, brain sections were placed in 4%
phosphate-buffered paraformaldehyde and fixed for 1 hour
at room temperature. Sections were rinsed three times in
2 3 standard saline citrate (SSC; 1 3 SSC 5 150 mM
sodium chloride and 15 mM sodium citrate). Slides were
then placed in a solution of 0.1 M triethanolamine with
0.25% acetic acid for 10 minutes. The tissue was rinsed in
water and dehydrated through a series of alcohols.
Dig-UTP- and [35S]-labeled probes were diluted together
in hybridization buffer (50% formamide; 10% dextran
sulfate; 3 3 SSC; 50 mM sodium phosphate buffer, pH 7.4;
1 3 Denhardt’s solution; 0.1 mg/ml yeast tRNA; and 10
mM DTT) to yield an approximate concentration of 2–2.5 3
106 c.p.m./65 µl. Appropriate dilutions for nonradioactive
probes were estimated from pilot experiments. The follow-
ing probe combinations were run for the BSTov and the
CEAl: Dig-GAD 65/67 (used concomitantly as a marker for
GABAergic neurons) with [35S]-ENK, [35S]-NT, or [35S]-
CRH in naı̈ve animals; Dig-ENK, Dig-NT, or Dig-CRH
with [35S]-GAD 65/67 in naive animals; Dig-ENK with
[35S]-NT or [35S]-CRH in naive animals; Dig-c-fos with
[35S]-GAD 65/67, [35S]-ENK, [35S]-NT, or [35S]-CRH in
animals treated with IL-1b, 5 µg/kg i.p. Diluted probe (65
µl) was placed on each slide, and the sections coverslipped.
Slides were placed in plastic trays lined with filter paper
dampened with 50% formamide/50% water. Trays were
sealed and incubated at 55°C for 16 hours. Coverslips were
floated off in 2 3 SSC, and slides were rinsed an additional
three times in 2 3 SSC. Sections were incubated in RNase
A (200µg/ml) at 37°C for 60 minutes and rinsed in 2 3 SSC,
1 3 SSC, 0.5 3 SSC, and 0.1 3 SSC. Tissue was washed to
a final stringency of 0.1 3 SSC at 65°C for 60 minutes
Slides were then cooled to room temperature in 0.13 SSC.
After this posthybridization treatment, sections were
processed for detection of the nonradioactive probe. Sec-
tions were rinsed in 0.1 M phosphate buffer, pH 7.4, and
incubated for 2–4 hours at room temperature in a blocking
solution (0.25% carrageenan, 0.5% Triton-X 100, 0.1 M
phosphate buffer, pH 7.4). Sections were then incubated at
room temperature overnight with an antibody against Dig
conjugated to alkaline phosphatase (sheep anti-Dig-AP,
Fab fragments; Boehringer Mannheim) diluted 1:20,000 in
blocking solution. Sections were then washed three times
in 0.1 M phosphate buffer, twice in Tris-buffered saline,
and once in alkaline substrate buffer (ASB; 100 mM Tris
base, 50 mM NaCl, 50 mM MgCl2, pH 9.5). The color
reaction was carried out in the dark at room temperature
in ASB containing 5% polyvinyl alcohol (Sigma, St. Louis,
MO), 0.025% levamisole (Sigma), 0.45% 4-nitro blue tetra-
zolium chloride (NBT; Boehringer Mannheim) and 0.35%
5-bromo-4-chloro-3-indoyl-phosphate, 4-toluidine salt
(BCIP; Boehringer Mannheim). The color reaction took
6–24 hours, depending on the probe, and sections were
examined under a microscope to determine reaction comple-
tion. Slides were then washed extensively in water. Sec-
tions were incubated in 0.1 M glycine and 0.5% Triton-X
100, pH 2.2, for 10 minutes at room temperature to remove
the antibody (Hauptmann and Gerster, 1994) and then
washed in water. Finally, sections were fixed in 2.5%
glutaraldehyde for 1 hour, washed in water, and air dried.
The glycine and glutaraldehyde steps were found to help
prevent the increase in color background observed after
the development of emulsion dipped slides (see below).
Sections initially were exposed to x-ray film (Biomax-MR;
Eastman-Kodak, Rochester, NY) for 1–3 days, then dipped
in emulsion (Ilford KD-5; Polysciences, Warrington, PA),
and stored in light-tight boxes at 4°C for 2–14 days. After
development (Kodak D-19) of dipped slides, sections were
either coverslipped with an aqueous mounting medium
(Polysciences), which enabled the visualization of white
matter tracts that were used as anatomical landmarks, or
dehydrated in alcohols and then mounted in a xylene-
based mounting medium (Permount) for photomicro-
graphs.
Data analysis
The cellular distribution of different mRNA combina-
tions from dual ISH experiments was determined by using
a Leica microscope (Leitz DMR; Wetzlar, Germany). Nonra-
dioactive riboprobes were visualized under brightfield as a
blue-purple precipitate, whereas radioactive probes were
visualized under darkfield by using silver grain distribu-
tion. Sections at 60–160 µm intervals from three to six
animals per group were analyzed throughout the rostral-
caudal extent of the BSTov and the CEAl. Cell profile
counts were determined at 340 magnification with the aid
of an eye-piece grid (500 µm 3 500 µm divided into 100
squares). No attempt was made to establish absolute
numbers of cells within these structures. Rather, the
numbers of cell profiles counted for each animal were used
to calculate the relative percent colocalization of mRNA for
that animal. The mean 6 S.E.M. percent colocalization for
each probe combination with respect to the nonradioactive
probe (see Technical considerations, below) is reported in
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Tables 1 and 2. The cell numbers reported in Tables 1 and 2
reflect the total numbers of cell profiles counted for all
animals combined. The grid was centered over the area of
peak expression of mRNA labeled with the nonradioactive
probe within the boundaries of the nucleus. Neuroanatomi-
cal boundaries of the BSTov, CEAl, medial CEA (CEAm),
and capsular CEA (CEAc) were determined according to
the atlas of Swanson (1992) by using white matter tracts
as a guide. It should be noted that the type of tissue
processing involved with the dual ISH technique pre-
cluded further regional compartmentalization within the
CEA. Both the left and right BSTov were included in the
analysis. For the CEAl, analysis was limited to the right
side. Previous quantitative results did not indicate differ-
ences in c-fos mRNA expression between the left and right
sides (Day and Akil, 1996), and results from the current
study did not suggest qualitative differences in the neuro-
chemical identity of activated cells between the two sides.
Photography and image processing
With the exception of Figure 5, photomicrographs were
taken by using a Zeiss Axiophot microscope (Thornwood,
NY), using Kodak Tmax-100 film (for darkfield images) or
Kodak Ektachrome Tungsten film (for brightfield and
double-exposure dual ISH photomicrographs). Slides and
negatives were converted to digital form by using a
Polaroid Sprint Scanner and Adobe Photoshop software
(version 4.0; Adobe Systems, Mountain View, CA) on a
Macintosh computer (Apple Computers, Cupertino, CA).
Images were adjusted by using one ‘‘sharpen’’ filter and
increased brightness and contrast to allow photographic-
quality prints to be generated. Color images also under-
TABLE 1. Coexpression of Enkephalin, Neurotensin, Corticotropin-Releasing Hormone, and Glutamic Acid Decarboxylase 65/67 mRNAs in the Oval









w.r.t. Dig (%) S.E.M. No.
BSTov
Expression of GAD65/67 mRNA in cells containing ENK, NT, or CRH mRNA
ENK GADs 0 nc 781 100 0 3
NT GADs 0 nc 151 100 0 3
CRH GADs 0 nc 427 100 0 4
Expression of ENK, NT, or CRH mRNA in cells expressing GAD65/67 mRNA
GADs ENK 632 nc 432 41 3.1 3
GADs NT 505 98 360 43 4.1 3
GADs CRH 1,913 142 587 24 3.2 3
Expression of NT or CRH mRNA in cells expressing ENK mRNA2
ENK NT 900 321 103 10 0.9 3
ENK CRH 947 382 10 1 0.4 3
CEAl3
Expression of GAD65/67 mRNA in cells containing ENK, NT, or CRH mRNA
ENK GADs 0 2,045 4,507 100 0 4
NT GADs 0 nc 309 100 0 4
CRH GADs 0 nc 464 100 0 4
Expression of ENK, NT, or CRH mRNA in cells expressing GAD65/67 mRNA
GADs ENK 1,639 nc 5,328 77 4.1 4
GADs NT 2,450 215 1,116 32 0.9 3
GADs CRH 2,241 161 698 24 1.5 3
Expression of NT or CRH mRNA in cells expressing ENK mRNA2
ENK NT 6,777 1,425 629 9 1.0 5
ENK CRH 2,581 729 13 0.5 0.1 4
1Total cell counts for double in situ hybridization experiments in the oval nucleus of the bed nucleus of the stria terminalis (BSTov) and the lateral division of the central nucleus of
the amygdala (CEAl) for the expression of mRNA encoding glutamic acid decarboxylase isoforms 65 and 67 (GADs) in cells expressing enkephalin (ENK), neurotensin (NT), or
corticotropin-releasing hormone (CRH) mRNA; and the expression of mRNAs encoding the peptides ENK, NT, or CRH in cells expressing GAD65/67 mRNA. Note that ‘‘no. cells’’
represents the total number of cells counted for all animals. The percent of colocalization was calculated relative to the digoxigenin (Dig) probe for each animal separately, according
to the following formula: no. doubles 4 (no. doubles 1 no. Dig-only) 3 100. The mean percentage colocalization relative to the Dig-labeled probe was calculated from these values.
w.r.t., with respect to; S.E.M., standard error of the mean; nc, not counted.
2The expression of mRNAs encoding the peptides NT or CRH in ENK mRNA-containing neurons.
3Note that cell counts were taken within the area of peak expression for each peptide mRNA, but there was significant variation in the percentage of colocalization across the region
due to the differential mRNA distribution.
TABLE 2. Coexpression of c-fos mRNA With Enkephalin, Neurotensin, Corticotropin-Releasing Hormone, or Glutamic Acid Decarboxylase 65/67 mRNAs
in the Oval Nucleus of the Bed Nucleus of the Stria Terminalis and Lateral Division of the Central Nucleus of the Amygdala









w.r.t. Dig (%) S.E.M. No.
BSTov
Fos GADs 3 1,791 769 100 0.1 4
Fos ENK 110 1,767 473 81 1.4 4
Fos NT 401 1,043 119 23 0.5 4
Fos CRH 787 1,316 34 4 1.4 4
CEAL
Fos GADs 0 nc 4,168 100 0 6
Fos ENK 133 nc 2,168 94 1.3 4
Fos NT 1,814 2,012 468 22 1.8 5
Fos CRH 1,728 806 17 1 0.5 3
1Total cell counts for double in situ hybridization experiments in the oval nucleus of the bed nucleus of the stria terminalis (BSTov) and the lateral division of the central nucleus of
the amygdala (CEAl) for the expression of glutamic acid decarboxylase isoforms 65 and 67 (GADs), enkephalin (ENK), neurotensin (NT), or corticotropin-releasing hormone (CRH)
mRNA in c-fos mRNA-positive cells 30 minutes after the administration of interleukin-1b (5 µg/kg, i.p.). Note that ‘‘no. cells’’ represents the total number of cells counted for all
animals. The percent of colocalization was calculated relative to the digoxigenin (Dig) probe for each animal separately according to the following formula: no. doubles 4 (no.
doubles 1 no. Dig-only) 3 100. The mean percentage colocalization relative to the Dig-labeled probe was calculated from these values. w.r.t., with respect to; nc, not counted.
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went a color transformation (image: variations: ‘‘more
blue’’) to provide optimal contrast between silver grains,
Dig-labeled cells, and background. Each image in a composite
set was processed in an identical manner. Figure 5 was
generated digitally. Brightfield and darkfield images were
captured separately with a Sony CCD video camera (DXC-
970MD; Sony Corp., Tokyo, Japan) attached to a Leica
(Leitz DMR) microscope. Brightfield and darkfield images
were then overlaid to produce a single image by using the
MCID image-analysis system (MCID, Ontario, Canada). The
composite was formed within Adobe Photoshop. Brightness
and contrast were altered to the same degree for each
picture within the composite to generate a photographic-
quality print. Schematic diagrams were adapted from the
atlas of Swanson (1992) by using Adobe Illustrator (ver-
sion 7.0; Adobe Systems).
RESULTS
Initial studies indicated that the nonradioactive ISH
technique was less sensitive than the radioactive ISH
technique, in that the numbers of cells observed to be
labeled after hybridization with a Dig-labeled probe were
less than those observed with a similar [35S]-labeled probe.
For example, sections from the striatum of one animal
were labeled concurrently with Dig-ENK and [35S]-ENK
(Fig. 1A). Every cell that was positive for Dig-ENK also
was positive for [35S]-ENK (485 cells counted). In contrast,
only 94% of cells that were positive for [35S]-ENK also were
positive for Dig-ENK (33 cells were positive for [35S]-ENK
alone). Hence, the results of the current study are ex-
pressed with respect to the Dig-labeled probe (Tables 1, 2).
For probe combinations in which results were required
with respect to both probes, two series of sections were
analyzed; for example, Dig-ENK with [35S]-GAD65/67 and
Dig-GAD65/67 and [35S]-ENK.
Expression of peptide mRNA in GABAergic
neurons of the BSTov and CEAl
The general patterns of expression of CRH, ENK, NT,
GAD65, and GAD67 mRNAs were consistent with previ-
ous reports (Harlan et al., 1987; Alexander et al., 1989;
Esclapez et al., 1994; Makino et al., 1994). All of these
mRNAs were expressed within the BSTov (Fig. 2) and the
Fig. 1. Photomicrographs (double exposure) of control double in
situ hybridization experiments using the following probes: A: Digoxi-
genin-enkephalin (Dig-ENK) 1 [35S]-ENK in the striatum demonstrat-
ing the extent of colocalization of the two labeled probes with one
another. B: Dig-ENK 1 [35S]-glutamic acid decarboxylase 65/67
(GAD65/67) in the paraventricular nucleus of the hypothalamus
(PVH) demonstrating the lack of colocalization of ENK and g-aminobu-
tyric acid (GABA) in this nucleus compared with that observed in the
oval nucleus of the bed nucleus of the striatum (BSTov) and the lateral
division of the central nucleus of the amygdala (CEAl). C: Dig-Fos 1
[35S]-GAD65/67 in the PVH 30 minutes after interleukin-1b (IL-1b;
5 µg/kg, i.p.) demonstrating the lack of colocalization of c-fos mRNA
and GABA in this nucleus compared with that observed in the BSTov
and CEAl. D: Dig-Fos 1 [35S]-corticotropin-releasing hormone (CRH)
in the PVH 30 minutes after IL-1b (5 µg/kg, i.p.) demonstrating the
significant colocalization of c-fos and CRH mRNA in this nucleus
compared with that observed in the BSTov and CEAl. Open arrows
indicate cells hybridized with the Dig-labeled probe only. Solid white
arrows indicate cells hybridized with the [35S]-labeled probe only. Solid
black arrows indicate double-labeled cells. Scale bars 5 50 µm.
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CEAl (Fig. 3), with GAD65/67 and ENK mRNAs more
abundant than CRH and NT mRNAs. GABAergic and
peptidergic neurons exhibited specific patterns of expres-
sion within these nuclei. GAD65 and GAD67 mRNAs were
observed throughout the BST and CEA, with high levels in
both the lateral and medial divisions (Figs. 2B, 3B).
Expression of ENK mRNA was high throughout the BSTov
(Fig. 2C) and the CEAl (Fig. 3C), but some labeled cells
also were observed in the CEAm. Expression of NT mRNA
was moderate in the BSTov and CEAl (Figs. 2D, 3D).
Expression of NT mRNA was highest in the dorsal and
medial aspects of the CEAl, with some cells also observed
in the CEAm (Fig. 3D). For CRH mRNA, expression within
the BSTov was greater toward the medial extent of this
nucleus (Fig. 2E). Within the CEA, CRH mRNA was
localized mainly to the lateral division, with expression
greatest within the central region of the CEAl (Fig. 3E).
Expression of CRH mRNA was observed throughout the
Fig. 3. A: Schematic diagram of the CEA. B–E: Distribution in the
CEA of mRNAs encoding GAD65/GAD67 (B), ENK (C), NT (D), and
CRH (E). Dashed lines delineate anatomical subdivisions as indicate
in A. CEAl, lateral division of the CEA; CEAm, medial division of the
CEA; CEAc, capsular division of the CEA; st, stria terminalis; BLA,
basolateral amygdaloid nucleus. Scale bar 5 300 µm.
Fig. 2. Distribution of mRNA encoding GAD65/GAD67 (A), ENK
(B), neurotensin (NT; C), and CRH (D) in the BSTov. Dashed lines
delineate anatomical subdivisions as indicated in C. Divisions of the
bed nucleus of the stria terminalis (BST): a, anterior; ju, juxtacapsular
nucleus; ov, oval nucleus; int, internal capsule; VL, lateral ventricle.
Scale bar 5 200 µm.
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rostral-caudal extent of the CEAl but was highest at
midlevels, caudal to the paraventricular nucleus of the
hypothalamus (PVH).
Within the CEAl and BSTov, every cell that expressed
either CRH, ENK, or NT mRNA (Dig-labeled probe) also
expressed GAD65/67 mRNA ([35S]-labeled probe; Fig. 4).
The 100% colocalization of the peptide mRNAs with
GAD65/67 is unlikely to be due to a nonspecific interaction
of the probes. For example, within the reticular nucleus of
the thalamus, GAD65/67 mRNA did not colocalize with
either CRH, ENK, or NT mRNA (data not shown). Fur-
thermore, within the PVH, neither CRH nor ENK mRNA
was coexpressed with GAD65/67 mRNAs (shown for Dig-
ENK with [35S]-GAD65/67 in Fig. 1B). However, not all
GABAergic cells (Dig-labeled GAD65/67 mRNA) also con-
tained a particular peptide mRNA ([35S]-labeled probe).
The percentage of colocalization varied, particularly across
the CEA, because of the differential distributions of each of
the peptide mRNA species. However, the greatest colocal-
ization for both the BSTov and the CEAl was observed for
ENK, with up to 75% of GABAergic neurons containing
this peptide (BSTov: 41% 6 3.1%; n 5 3; CEAl: 77% 6
2.1%; n 5 4). Fewer GABAergic cells expressed NT or
CRH. Within the area of peak expression of CRH in both
the BSTov and the CEAl, <25% of neurons that were
positive for GAD65/67 also expressed CRH mRNA (BSTov:
24% 6 3.2%; n 5 3; CEAl: 24% 6 1.5%; n 5 3). The ratio
was slightly higher at the peak of NT expression (BSTov:
43% 6 4.1%; n 5 3; CEAl: 32% 6 0.9%; n 5 3). The
expression of NT or CRH in ENK-containing cells revealed
a highly specific pattern of colocalization (Fig. 5). There
was some colocalization of NT in ENK mRNA-containing
cells (BSTov: 10% 6 0.9%; n 5 3; Fig. 5A; CEAl: 9 6 1.0%;
n 5 5; Fig. 5B). However, extremely few ENK-positive cells
Fig. 4. A–F: Photomicrographs (single exposures) of double in situ
hybridization experiments showing the colocalization of GAD65 and
GAD67 mRNA ([35S]-labeled probe; Aii–Fii) with various peptides
(Dig-labeled probe; Ai–Fi) in the BSTov (Ai,Aii; Ci,Cii; Ei,Eii) and the
CEAl (Bi,Bii; Di,Dii; Fi,Fii). A: Dig-ENK 1 [35S]-GAD65/67 in the
BSTov. B: Dig-ENK 1 [35S]-GAD65/67 in the CEAl. C: Dig-NT 1
[35S]-GAD65/67 in the BSTov. D: Dig-NT 1 [35S]-GAD65/67 in the
CEAl. E: Dig-CRH 1 [35S]-GAD65/67 in the BSTov. F: Dig-CRH 1
[35S]-GAD65/67 in the CEAl. Dark arrows indicate cells expressing
peptide mRNA (Dig-labeled probe). Light arrows indicate the same
cells labeled for [35S]-GAD65/67 mRNA. Every cell that expressed
either ENK, CRH, or NT also expressed GAD65/67 mRNA. Scale bar 5
50 µm.
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expressed CRH mRNA (BSTov: 1.2% 6 0.4%; n 5 3; Fig.
5C; CEAl: 0.5% 6 0.1%; n 5 4; Fig. 5D).
Expression of c-fos mRNA
in neurochemically defined
neurons of the BSTov and CEAl
A marked increase in c-fos mRNA expression was ob-
served in the BST (Fig. 6) and the CEA (Fig. 7) 30 minutes
after administration of IL-1b (5 µg/kg, i.p.) compared with
saline-injected controls, consistent with results from previ-
ous studies (Brady et al., 1994; Day and Akil, 1996). Within
the BST, expression was highly discrete, with the majority
of labeled cells observed within the BSTov. Furthermore,
expression of c-fos mRNA within the BSTov was most
abundant toward the lateral extent of this nucleus. Expres-
sion of c-fos mRNA within the CEA was localized essen-
tially to the CEAl, with very few labeled cells observed in
the CEAm or CEAc. Expression of c-fos mRNA was ob-
served throughout the CEAl but was strongest in the
ventrolateral region, caudal to the PVH.
The IL-1b-induced expression of c-fos mRNA in cells of
the BSTov and CEAl was determined with respect to
colocalization in GABAergic (as defined by the expression
of GAD65 and/or GAD67 mRNA) or peptidergic (CRH,
ENK, or NT mRNA-containing) cells. A striking parallel
was noted between the neurochemical identity of Fos-
positive cells in the BSTov and CEAl, as shown in Figures
8 and 9. Cells that expressed c-fos mRNA in either the
BSTov (Figs. 8A, 9) or the CEAl (Figs. 8B, 9) invariably
expressed GAD65/67 mRNA (BSTov, n 5 4; CEAl, n 5 6).
The 100% colocalization of c-fos mRNA in GABAergic cells
was specific for these nuclei. Other areas that expressed
GAD65/67 mRNA, for example, the reticular thalamic
nucleus, did not express c-fos mRNA (data not shown), and
c-fos mRNA-containing cells of the PVH did not express
GAD65/67 mRNA (Fig. 1C). In addition, in both the BSTov
(Figs. 8C, 9) and the CEAl (Figs. 8D, 9), the majority of
cells expressing c-fos mRNA in the BSTov (81% 6 1.4%;
n 5 4) and CEAl (94% 6 1.3%; n 5 4) also expressed ENK
mRNA. A smaller population of cells positive for c-fos
mRNA in the BSTov (Figs. 8E, 9) and CEAl (Figs. 8F, 9)
expressed NT mRNA (BSTov: 23% 6 0.5%; n 5 4; CEA:
22% 6 1.8%; n 5 5). Very few cells that expressed c-fos
mRNA in the BSTov (Figs. 8G, 9) and CEAl (Figs. 8H, 9)
also expressed CRH mRNA (BSTov: 4% 6 1.4%; n 5 4;
CEA: 1% 6 0.5%; n 5 3). This result is in contrast to that
observed for CRH and c-fos mRNAs in the PVH, where
there is substantial overlap of expression (Fig. 1D), in
agreement with previous observations after intravenous
infusion of IL-1b (Veening et al., 1993; Ericsson et al.,
1994).
Fig. 5. Photomicrographs (double exposure) of double in situ
hybridization experiments showing the extent of colocalization of ENK
mRNA (Dig-labeled probe) with NT (A,B) or CRH (C,D) mRNAs
([35S]-labeled probes) in the BSTov (A,C) and the CEAl (B,D). White
arrows indicate cells hybridized with the Dig-labeled probe only. Black
arrows indicate double-labeled cells. Scale bar 5 100 µm.
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DISCUSSION
The data presented in the current study provide evi-
dence for neurochemically distinct subsets of cells in the
BSTov and CEAl and suggest that these subpopulations
may be activated differentially by systemic IL-1b. The
mRNA encoding for the peptides ENK, NT, and CRH
invariably is expressed in GABAergic cells in these re-
gions. Although there is some colocalization of ENK and
NT mRNAs, enkephalinergic cells rarely express CRH
mRNA in either the BSTov or the CEAl. The demonstra-
tion that systemic administration of IL-1b causes the
robust activation of enkephalinergic cells but extremely
sparse activation of CRH-containing cells (as determined
by c-fos mRNAexpression) suggests that these neurochemi-
cally defined neuronal subsets of the BSTov and CEAl may
have differential functions. Furthermore, the proportion of
neurochemically similar and functionally activated cells
showed remarkable similarities between the BSTov and
the CEAl, consistent with the concept of an extended
amygdala.
Technical considerations
In general, the dual-ISH method is a powerful tool for
studying the colocalization of two molecules in a single
neuron. This technique has the advantage over some
dual-immunocytochemistry methods, because it can be
used in animals without the severe stress of colchicine
pretreatment. However, for each combination of probes, a
number of considerations must be taken into account
before results can be validated. For example, tissue with
different levels of expression should be used to control for
nonspecific probe interactions in cases in which a high
degree of colocalization is observed and to control for
quenching when a low degree of colocalization is observed.
Specific examples are described in the Results (above) and
are illustrated in Figure 1. Furthermore, a particular
consideration lies in the fact that the nonradioactive ISH
technique is less sensitive than the radioactive ISH tech-
nique, so that the numbers of cells observed to be labeled
after hybridization with a Dig-labeled probe are less than
those observed with a similar [35S]-labeled probe. Because
of this technical limitation, the results expressed relative
to the [35S]-labeled probe are misleading, because they
underestimate the proportion of double-labeled cells.
Hence, data from the current study were expressed with
respect to the Dig-labeled probe. It also should be noted
that a cell profile count methodology was used to generate
these data, which inherently leads to a biased count of
absolute cell numbers (Coggeshall and Lekan, 1996).
However, we did not attempt to determine the absolute
numbers of cells, and this counting method is suitable to
estimate the approximate proportion of cells expressing a
particular mRNA (Saper, 1996). Caution also must be
exercised when interpreting c-fos mRNA expression and,
more specifically, the lack of expression of this gene in
different cell populations. In particular, the lack of expres-
sion in CRH mRNA-containing cells is discussed in detail
below. Finally, it should be kept in mind that a single dose
of IL-1b, and a single time point was used in the present
study. The experimental conditions, as discussed in more
detail below, were chosen to elicit a robust increase in c-fos
mRNA expression at the time of peak expression. Although
a dose-response curve was not run in the present experi-
ment, the dose used was comparable to that used in
several other studies. For example, studies to establish the
role of vagal afferents after intraperitoneal administration
of IL-1b have used doses of 2 µg/kg i.p. IL-1b (Watkins et
Fig. 6. A: Schematic diagram of the BSTov. B,C: Distribution of
c-fos mRNA in the BSTov 30 minutes after administration of 0.9%
saline, i.p.(B), or IL-1b (5 µg/ml/kg i.p.; C). Dashed lines delineate
anatomical subdivisions as indicated in B. Divisions of the anterior
BST: al, anterolateral area; cc, central core, anterodorsal area; ju,
juxtacapsular nucleus; ov, oval nucleus; CP, caudate putamen; int,
internal capsule; LSv, lateral septal nucleus, ventral part; VL, lateral
ventricle; zl, zona limitans. Scale bar 5 200 µm.
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al., 1995), 10 µg/kg i.p. IL-1b (Fleshner et al., 1995), and 4
µg/kg or 20 µg/kg i.p. IL-1b (Kapcala et al., 1996).
Neurochemical determination
of subpopulations of neurons
of the BSTov and CEAl
It has long been known that the BSTov and CEAl are
highly GABAergic (Sun and Cassell, 1993) and that opioid
peptide-like immunoreactivity is localized in GABAergic
neurons of the rat CEA (Oertel et al., 1983). More recently,
a study using immunocytochemistry on adjacent sections
suggested that GABAergic neurons of the central extended
amygdala synthesize either CRH or ENK (Veinante et al.,
1997). However, the extent of colocalization of different
peptides in GABAergic cells has not been demonstrated
previously. Data presented in this paper suggest that
every cell that expresses ENK, NT, or CRH mRNA in the
BSTov and CEAl is GABAergic. However, as expected, not
all GABAergic cells in these regions express the mRNA
encoding these peptides. In addition, it is important to
note the widespread expression of GAD65/67 mRNA ob-
served in the medial division of the CEA, the major source
of CEA efferent projections. In keeping with this, it has
been demonstrated recently that efferents from the CEA
form inhibitory type synapses with neurons in the rat NTS
(Pickel et al., 1995) and that the CEA projection to the
medulla is mostly GABAergic (Jia et al., 1997). Together,
these data suggest that the major output of the CEA may
be inhibitory rather than excitatory. Within the BSTov and
CEAl, < 10% enkephalinergic neurons were found to
coexpress NT mRNA, whereas enkephalinergic neurons
rarely expressed CRH mRNA. Although we did not investi-
gate the overlap between NT and CRH mRNAs in the
present study, a previous study has shown that 80% of NT
cells in the BSTov and 80–90% of NT cells in the CEAl were
immunoreactive for CRH (Shimada et al., 1989). Hence,
there appear to be two major subpopulations of GABAergic
neurons: one containing CRH and one containing ENK,
with NT expressed to differing extents within these neu-
rons.
The potential activation of these distinctive neuronal
subpopulations was investigated after i.p. administration
of IL-1b, because our group and others have demonstrated
that this stimulus results in activation of both the BSTov
and the CEAl, as determined by the expression of c-fos
mRNA. Although it was not demonstrated directly, the
data presented in the current study suggest that the
majority of the IL-1b-responsive neurons of the BSTov and
CEAl contain both GAD65/67 and ENK mRNAs. Smaller
proportions of activated neurons appear to contain both
GAD65/67 and NT mRNAs. It is not clear whether these
represent distinct populations or whether some of the
activated GABAergic neurons express both NT and ENK.
However, despite the generally high degree of colocaliza-
tion between CRH and NT (Shimada et al., 1989), it seems
likely that, given the lack of colocalization of CRH and
c-fos mRNAs, the NT mRNA-containing cells that were
activated by IL-1b represent a specific subpopulation of
NT cells that do not contain CRH.
The lack of c-fos mRNA in CRH cells is difficult to
interpret definitively. It is unlikely that CRH-containing
cells are unable to express c-fos mRNA, because they have
been shown to express Fos protein after nicotine adminis-
tration (Matta et al., 1997). It also is possible that a
different dose of IL-1b or a different time after injection
would elicit c-fos mRNA expression in CRH cells. However,
we believe that this is unlikely, because the dose employed
in this study was relatively high, and c-fos mRNA peaks
early in these areas after i.p. injection and returns to basal
levels after 3 hours (Brady et al., 1994). It is not clear from
the present data whether or not i.p. IL-1b increases
expression of other transcription factors in CRH mRNA-
containing cells, and the lack of expression of c-fos mRNA
certainly does not preclude these cells from being involved
in the coordinated response of the animal to this stimulus.
Fig. 7. A: Schematic diagram of the central nucleus of the amyg-
dala (CEA). B,C: The distribution of c-fos mRNA 30 minutes after
administration of 0.9% saline, i.p. (B) or IL-1b (5 µg/ml/kg, i.p.; C).
Dashed lines delineate anatomical subdivisions as indicated in A. For
abbreviations, see Figure 3. Scale bar 5 200 µm.
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Fig. 8. Photomicrographs (double exposure) of double in situ
hybridization experiments showing the extent of colocalization of c-fos
mRNA (Dig-labeled probe) 30 minutes after IL-1b administration
(5µg/ml/kg, i.p.) with GAD65 and GAD67 (A,B), ENK (C,D), NT (E,F),
and CRH (G,H) mRNAs ([35S]-labeled probes) in the BSTov (A,C,E,G)
and the CEAl (B,D,F,H). White arrows indicate cells that contain c-fos
mRNA alone. Magenta arrows indicate double-labeled cells that
contain c-fos mRNA with the appropriate radioactive-labeled marker.
Scale bar 5 100 µm
However, we believe it is most likely that these cells are
under active inhibition, as is discussed below. Neverthe-
less, the present data indicate the existence of neurochemi-
cally distinctive subpopulations within the BSTov and
CEAl and suggest that they may represent functionally
discrete neural circuits that may be activated differen-
tially by a specific stimulus.
Potential functional implications
of activation of the BSTov and CEAl by IL-1b
Although, currently, there are no data regarding specific
functional roles for CRH- versus ENK-containing cells of
the BSTov and CEAl, we hypothesize that differential
activation of these neurochemically distinct neuronal popu-
lations allows the BSTov and CEAl to subserve different
functional roles. The similarities in c-fos mRNA expression
between the two nuclei are consistent with the anatomical
concept of an extended amygdala (for review, see Alheid et
al., 1995), and, broadly, these two nuclei have been linked
functionally. Furthermore, it has been argued recently
that the terms ‘‘amygdala’’; or ‘‘amygdalar complex’’; com-
bine cell groups arbitrarily (Swanson and Petrovich, 1998);
indeed, it is possible that, functionally, the CEAl would be
better classified with the BSTov than within the amygda-
lar complex.
Of particular interest to our laboratory is the regulation
of the hypothalamic-pituitary-adrenal (HPA) axis, the
activation of which is a defining feature of a stress
response. Several studies have indicated that both the
CEA and the BST play a role in the regulation of stress-
induced adrenocorticotropin hormone (ACTH) and cortico-
sterone release, with the suggestion that this regulation is
effected directly at the level of the PVH (Dunn, 1987; Gray
et al., 1989, 1993). Although administration of IL-1b
results in activation of the HPA axis (Besedovsky et al.,
1986), the BSTov and CEAl express very low levels of c-fos
mRNA after a variety of other stressors, including re-
straint, swim stress (Cullinan et al., 1995), audiogenic
stress (Campeau and Watson, 1997), and fear conditioning
(Campeau et al., 1997). Hence, c-fos mRNA expression
within the BSTov and CEAl is not a feature common to the
central response to acute stress. Furthermore, although
early anatomical evidence suggested that the CEA pro-
vides direct input to the PVH (Gray et al., 1989), more
recent studies using highly discrete injections of the
retrograde tracer FluoroGold into the parvocellular (CRH-
containing) regions of the PVH indicate that neither the
BSTov nor the CEA provide direct input to the parvocellu-
lar PVH (Cullinan et al., 1996; Prewitt and Herman,
1998). Of particular relevance is the recent study of Lee et
al. (1998), who described an anatomical dissociation of the
c-fos mRNA response to intravenous IL-1b. Although
lesions of the area postrema inhibited the IL-1b-induced
ACTH response and c-fos mRNA response in the NTS and
PVH, these lesions did not affect the IL-1b-induced c-fos
mRNA expression in the BST or CEA. Taken together, we
propose that the c-fos mRNA expression in the BSTov and
CEAl after the administration of IL-1b does not reflect a
primary role for these nuclei in HPA axis regulation.
However, it is noteworthy that the majority of ENK-, NT-,
and CRH-containing neurons of the CEA also contain
glucocorticoid receptor immunoreactivity (Honkaniemi et
al., 1992): Thus, these neurons probably are influenced by
glucocorticoids released by IL-1b.
Many studies have suggested that the BSTov and CEA
are involved in central autonomic regulation (for review,
see Saper, 1995). The visceral nature of a systemic immune
challenge suggests that the activation of these areas by
IL-1b indeed may reflect an autonomic role. Administra-
tion of IL-1b results in a number of autonomic responses,
such as inhibition of gastric acid secretion (Saperas et al.,
1992), and the CEA in particular has been linked with this
function (Henke et al., 1991). Administration of IL-1b also
results in complex cardiovascular effects (Weinberg et al.,
1988; Bataillard and Sassard, 1994), and many studies
have demonstrated the roles that the BST and CEA play in
cardiovascular responses (Loewy and McKeller, 1980; Iwata
et al., 1987; Gelsema et al., 1989; Lewis et al., 1989; Roder
and Ciriello, 1993). It is noteworthy that Fos protein
expression has been demonstrated in the CEA and may be
associated with various cardiovascular parameters, includ-
ing hypotension with bradycardia and hypertension with
tachycardia (Graham et al., 1995). Furthermore, in an-
other model of immune challenge, systemic administration
of endotoxin at a dose that did not alter blood pressure but
caused tachycardia, also elicited robust Fos protein expres-
sion in the CEA (Tkacs et al., 1997). Hence, it appears that
Fos may be induced in the CEA under a variety of different
cardiovascular conditions, and it would be interesting to
determine whether these different conditions elicit Fos in
different cell types of the CEA. In addition, administration
of IL-1b decreases feeding, and several other anorexic
agents also increase the expression of c-fos in the CEAl
and BSTov, although the neurochemical phenotype is not
known (Bonaz et al., 1993; Li and Rowland, 1995; Rowland
et al., 1996). Indeed, we believe it is unlikely that the
activation of ENK- versus CRH-containing cells is specific
Fig. 9. Graph illustrating the relative proportions of c-fos mRNA
expressing cells in the BSTov and the CEAl that expressed either
GAD65/67, ENK, NT or CRH mRNA, 30 minutes after administration
of IL-1b (5 µg/kg, i.p.).
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to an immune stimulus, because preliminary data suggest
that an i.p. injection of amphetamine elicits a broadly
similar neurochemical pattern of c-fos mRNA distribution
in these areas.
Neural circuits potentially involved
in IL-1b activation in the BSTov and CEAl
Although projections to and from IL-1b-activated cells of
the BSTov and CEAl were not defined in the present study,
it is important to think about the activated cells in terms of
neural circuitry rather than in isolation. A number of
elegant studies have been published that, together with
the current data, suggest specific neural circuitry is en-
gaged by i.p. IL-1b. In terms of activational pathways,
although the major afferent input to the BST is from the
amygdala (Weller and Smith, 1982; Alheid et al., 1995), the
GABAergic nature of the activated cells of the CEAl likely
precludes this cell group from directly activating the
BSTov. However, i.p. administration of IL-1b also results
in the expression of c-fos mRNA in the medial division of
the NTS and the lateral parabrachial nucleus (PBl; Brady
et al., 1994; Day and Akil, 1996). The NTS projects heavily
to the PB (Herbert et al., 1990) but also projects directly to
both the CEA and the BST (Ricardo and Koh, 1978).
Similarly, both the BSTov and the CEAl receive projections
from the PBl (Bernard et al., 1993; Krukoff et al., 1993;
Alden et al., 1994). Studies to lesion the PBl and NTSm or
to combine neuroanatomical tracers with Fos protein or
c-fos mRNA localization may help to ascertain whether or
not these nuclei are critical in the IL-1b activation of the
BSTov and CEAl. It is noteworthy that, in addition to
receiving afferents from the NTS, the PBl receives input
from the spinal cord (Slugg and Light, 1994), and a
transneuronal labeling technique has been used to demon-
strate a pathway from the spinal cord to the CEA through
the PB (Jasmin et al., 1997). Although the involvement of
spinal projections has not been demonstrated after sys-
temic administration of IL-1b, the possibility exists that a
spinal-parabrachial pathway may be involved in the acti-
vation of the BSTov and CEAl after systemic administra-
tion of IL-1b.
Although efferent projections from the BSTov and CEAl
have been demonstrated to the PB (Moga and Gray, 1985;
Moga et al., 1989), the dorsal vagal complex (Gray and
Magnuson, 1987), and the midbrain central gray (Gray
and Magnuson, 1992), current evidence suggests that
these projections do not arise from ENK-containing neu-
rons. Because the majority of c-fos mRNA-containing
neurons in the BSTov and CEAl also contain ENK, it
seems unlikely that the major projection pathway of the
activated cells is back to these areas. Two elegant studies
using the anterograde tracer Phaseolus vulgaris leucoag-
glutinin injected exclusively into subdivisions of the CEA
have demonstrated a relatively discrete population of
efferent projections from the CEAl (Petrovich and Swan-
son, 1997; Jolkkonen and Pitkänen, 1998). Cells within the
CEAl were shown to project intrinsically to other cells
within the CEAl and CEAm in addition to projections to
the BST and PB. ENK neurons of the CEAl, as discussed
above, do not appear to project to the PB (Moga and Gray,
1985), but an enkephalinergic projection from the CEA to
the BST has been demonstrated (Rao et al., 1987). Hence,
it seems likely that the activated neurons of the CEAl
observed in the present study project to the BST and/or
Fig. 10. Schematic diagram showing some of the pathways that
may be involved in the activation of enkephalinergic neurons of the
BSTov and CEAl, and some of the putative efferent projections from
these neurons. It should be noted that the involvement of the spinal
cord projection in activation of the parabrachial nucleus in this model
is speculative at this time. In addition, although this figure highlights
possible pathways involved in the c-fos mRNA response to the
intraperitoneal administration of IL-1b, it does not attempt to show all
possible projections to and from the illustrated nuclei. Asc, ascending;
NTS, nucleus tractus solitarius; PBl, parabrachial nucleus, lateral
division; CEAm, central nucleus, Amygdala, medical devision. For
other abbreviations, see Figure 1.
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intrinsically within the CEAl/m. Given the relatively
sparse activation of other regions of the BST, the medial
aspect of the CEA or the CRH mRNA-containing cells in
the CEAl and BSTov, it is conceivable that some or all of
these cell populations are under active inhibition by the
Fos-positive cells of the CEAl. The efferent projections of
the BSTov are less well defined. However, there is some
evidence to suggest that GABAergic cells of the BSTov
project intrinsically to posterior subdivisions of the BST,
whereas there does not seem to be a major GABAergic
projection from the BSTov to the CEA (Sun and Cassell,
1993). Hence, our working hypothesis is that the BSTov
and CEAl are activated in parallel by ascending projec-
tions from the brainstem, and the activated neurons most
likely project intrinsically within the BST or CEA. It
should be noted that, although the activated cell types (as
determined by c-fos mRNA expression) are GABAergic,
this does not imply an inhibitory output. Indeed, there is
the potential for significant complexity of response, depend-
ing on the degree of activation of intrinsic GABAergic
connections within and between the CEA and the BST that
will have a profound impact on whether the overall output
of these nuclei is inhibitory or excitatory. A simplified
schematic diagram of this hypothesis indicating some of
the potential connections of specific cells groups within the
BSTov and CEAl is shown in Figure 10.
In summary, cells of the BSTov and the CEAl which
express ENK, NT, or CRH mRNA, invariably are GABAer-
gic. Two distinct subpopulations of GABAergic neurons
exist within these areas: one containing ENK and the
other containing CRH. Both populations exhibit partial
overlap with NT (Shimada et al., 1989; current study). The
intraperitoneal administration of the cytokine IL-1b re-
sulted in the activation of a proportionally similar popula-
tion of neurochemically identified neurons in the BSTov
and CEAl. All neurons in these regions that expressed c-fos
mRNA were found to be GABAergic. The majority of these
neurons also contained ENK mRNA, and a smaller popula-
tion contained NT mRNA. However, very few neurons in
the BSTov or CEAl that expressed c-fos mRNA contained
CRH mRNA. The specificity of the response strongly
suggests that discrete neural circuits may be targeted
differentially within the BSTov and CEAl. In addition, the
present results are consistent with the concept of an
extended amygdala and demonstrate a specific coupling
between the CEAl and the BSTov through the activation of
distinct neurochemical subpopulations. Although the func-
tion of the activated neurons is not clear at present, it
seems probable that the c-fos mRNA expression observed
in the enkephalinergic cells of the CEAl and BSTov after
the administration of IL-1b reflects autonomic or somatic
regulation. Identification of the efferent targets of these
neurons, together with the neurochemical identification of
cell populations in the BSTov and CEAl responsive to other
stimuli, may help to elucidate the functional significance of
their activation.
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